Cite
HARVARD Citation
Strik, A. et al. (n.d.). P724 Unchanged infliximab serum concentrations after switching from the originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease: Results from a prospective study (SECURE). Journal of Crohn's and colitis. pp. S477-S478. [Online].